Mineralys Therapeutics, Inc. MLYS Market capitalization

Market capitalization at other companies

Lexicon PharmaceuticalsLXRX

$1.07B+281%

MannkindMNKD

$1.32B+8.5%

Oric Pharmaceuticals, Inc.ORIC

$1.42B+258%

Crinetics PharmaceuticalsCRNX

$3.8B+21.9%

Tenet HealthcareTHC

$16.11B+1.1%

MedtronicMDT

$103.96B-3.8%

FAQ

What is Mineralys Therapeutics, Inc.'s market capitalization?

Mineralys Therapeutics, Inc. (MLYS) reported market capitalization of $2.23B in Q1 2026.

How has Mineralys Therapeutics, Inc.'s market capitalization changed year-over-year?

Mineralys Therapeutics, Inc.'s market capitalization increased by 123.8% year-over-year, from $997.24M to $2.23B.

What is the long-term trend for Mineralys Therapeutics, Inc.'s market capitalization?

Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s market capitalization has grown at a 188.6% compound annual growth rate (CAGR), from $344.8M to $2.87B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.